What Rhythm Pharmaceuticals RYTM disclosed about refinancing plans How CHS B Pref CHSCO is solving the problems its peers cannot Flat 20260507 BCRX BioCryst Pharmaceuticals Inc drops 238 percent post Q4 2025 EPS miss despite 94 percent year over year revenue growth Ready RCD Trend Analysis Q4 2025 Earnings Fall Short JLS Nuveen quarterly earnings metrics remain undisclosed investors pause trades ahead of official management commentary SciSparc SPRC Stock Volume Ratio Slips 20260420 Real Estate Select Sector SPDR XLRE Leads Sector Losses Amid Geopolitical Uncertainty and Broad Market Pullback The market share dynamics in Ardmore ASC results Q1 2026 Profit Surprises